RADIOFREQUENCY ABLATION OF PAROXYSMAL AND PROLONGED PERSISTENT ATRIAL FIBRILLATION: ONE-YEAR FOLLOW-UP WITH THE USE OF CONTINUOUS SUBCUTANEOUS MONITORING

To reveal a one-year outcome of radiofrequency ablation in patients with paroxysmal and persistent atrial fibrillation using continuous subcutaneous monitoring, 258 patients aged 56±9 years (including 204 males) were examined and treated.

atrial fibrillation, left atrium, pulmonary veins, radiofrequency catheter ablation, long-term subcutaneous monitoring

1. Allessie M, Ausma, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation // J. Cardiovasc. Res. - 2002. - V.54. - P.230-246.

2. Haissaguerre M, Ja'is P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the PVs // N Engl J Med. Res. - 1998. - V.339. - P.659-666.

3. Ernst S, Schluter M, Ouyang F et al. Modification of the substrate for maintenance of idiopathic human atrial fibrillation // Circulation. Res. - 1999. - V.100. - P.2085-2092.

4. Oral H, Knight BP, Tada H et al. PV isolation for paroxysmal and persistent atrial fibrillation // Circulation. Res. - 2002. - V.105. - P.1077-1081.

5. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, Damiano RJ Jr., Davies DW, Haines DE, Haissaguerre M, Iesaka Y, Jackman W, Jais P, Kottkamp H, Kuck KH, Lindsay BD, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Natale A, Pappone C, Prystowsky E, Raviele A, Ruskin JN, Shemin RJ: HRS/ EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation // Heart Rhythm. Res. - 2007. - V4. - P.816-861.

6. Patten M, Maas R, Bauer P et al. Suppression of paroxysmal atrial tachyarrhythmias-results of the SOPAT trial // Eur Heart J. Res. - 2004. - V.25. - P.1395-1404.

7. Patten M, Maas R, Karim A et al. Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: Subanalysis of the SOPAT trial // J Cardiovasc Electrophysiol. Res. - 2006. - V.17. - P.1216-1220.

8. Hindricks G, Piorkowski C, Tanner H et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: Relevance of asymptomatic arrhythmia recurrence // Circulation. Res. - 2005. - V.112. - P.307-313.

9. Senatore G, Stabile G, Bertaglia E et al. Role of transtelephonic electrocardiographicmonitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation // J Am Coll Cardiol. Res. - 2005. - V.45. - P.873-876.

10. Pontoppidan J, Nielsen JC, Poulsen SH, Hansen PS: Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of Life // Pacing Clin Electrophysiol. Res. - 2009. - V.32. - P.717-726.

11. Quirino G, Giammaria M, Corbucci G et al. Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: Relationship to symptoms and other variables // Pacing Clin Electrophysiol. Res. - 2009. - V.32. - P.91-98.

12. Piorkowski C, Kottkamp H, Tanner H et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation // J Cardiovasc Electrophysiol. Res. - 2005. - V.16. - P.1286-1292.

13. Martinek M, Aichinger J, Nesser HJ et al. New insights into long-term follow-up of atrial fibrillation ablation: Full disclosure by an implantable pacemaker device // J Cardiovasc Electrophysiol. Res. - 2007. - V.18. - P.818-823.

14. Hanke T, Charitos EI, Stierle U et al. Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy up to 12 months experience with a novel permanently implantable heart rhythm monitor device // Circulation. Res. - 2009. - V120. - P.177-S184.

15. Botto GL, Padeletti L, Santini M et al. Presence and duration of atrial fibrillation detected by continuous monitoring: Crucial implications for the risk of thromboembolic events // J Cardiovasc Electrophysiol. Res. - 2009. - V.20. - P.241-248.

16. Ziegler PD, Koehler JL, Mehra R: Comparison of continuous versus intermittentmonitoring of atrial arrhythmias // Heart Rhythm. Res. - 2006. - V3. - P. 1445-1452.

17. Lee SH, Tai CT, Hsieh MH et al. Predictors of early and late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation // J Interv Card Electrophysiol. Res. - 2004. - V.10. - P.221-226.

18. Vasamreddy CR, Lickfett L, Jayam VK et al. Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter // J Cardiovasc Electrophysiol. Res. - 2004. - V15. - P.692-697.

19. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, P'urerfellner H, on behalf of the XPECT Trial investigators: Performance of a new implantable cardiac monitor in detecting and quantifying atrial fibrillation. Results of the XPECT Trial // Circ Arrhythm Electrophysiol. Res. - 2010. - V3. - P. 141-147.

20. Pokushalov E., Romanov A., Artemenko S. et al. Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation // Pacing Clin Electrophysiol. Res. - 2010. - V33. - P. 1231-8.

21. Pokushalov E, Romanov A, Artyomenko S et al. Ganglionated plexi ablation for long-standing persistent atrial fibrillation // Europace. Res. - 2010. - V.12. - P.342-346.

22. Лосик Д., Романов А., Туров А. и др. Первый опыт применения имплантируемого аппарата длительного мониторирования ЭКГ для контроля эффективности процедуры радиочастотной аблации ганглионарных сплетений при пароксизмальной форме фибрилляции предсердий // Вестник аритмологии - 2010. - №.61б. - C.52-56.

23. Jais P, Nault I, Wright M et al. Haissaguerre M: Early recurrences after atrial fibrillation ablation: Prognostic value and effect of early reablation // J Cardiovasc Electrophysiol. Res. - 2008. - V.19. - P.599-605. Arrhythm Electrophysiol. Res. - 2010. - V.3. - P.141-147.

24. Pollak WM, Simmons JD, Interian A et al. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter // Pacing Clin Electrophysiol. Res. - 2001. - V.24. - P.424-429.

25. Glotzer TV, Hellkamp AS, Zimmerman J et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke // Circulation. Res. - 2003. - V107. - P.1614-1619.

26. Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, De Santo T, Grammatico G, SantiniM, on behalf of DATAS study Investigators: Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: A subanalysis of the DATAS trial // Europace. Res. - 2009. - V.11. - P.587-593.

27. Glotzer TV, Daoud EG, Wyse DG et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. The TRENDS Study //. Circ Arrhythmia Electrophysiol. Res. - 2009. -V.2. - P.474-480.

28. Hoppe UC, Casares JM, Eiskjar H, et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure // Circulation. Res. - 2006. - V.114. - P.18-25.

29. Ip J, Waldo AL, Lip GYH et al. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort: The IMPACT study // Am Heart J. Res. - 2009. - V.158. - P. 364-370.e1.

30. Corbucci G, Urban L, Hatala R et al. Reliability of atrial fibrillation burden through subcutaneous devices // Europace. Res. - 2010. - V.12. - P.162